| Primary |
| Product Used For Unknown Indication |
17.2% |
| Pain |
14.0% |
| Drug Use For Unknown Indication |
12.8% |
| Back Pain |
10.9% |
| Hypertension |
8.1% |
| Osteoarthritis |
7.5% |
| Arthralgia |
5.1% |
| Rheumatoid Arthritis |
4.4% |
| Type 2 Diabetes Mellitus |
2.5% |
| Arthritis |
2.2% |
| Gout |
1.9% |
| Sciatica |
1.7% |
| Analgesic Therapy |
1.5% |
| Pain In Extremity |
1.5% |
| Pyrexia |
1.5% |
| Renal Pain |
1.5% |
| Hiv Infection |
1.4% |
| Osteoporosis |
1.4% |
| Myalgia |
1.3% |
| Parkinson's Disease |
1.3% |
|
| Vomiting |
16.2% |
| Renal Failure Acute |
12.8% |
| Weight Decreased |
7.7% |
| Urticaria |
5.1% |
| White Blood Cell Count Decreased |
5.1% |
| Pruritus |
4.7% |
| White Blood Cell Count Increased |
4.7% |
| Linear Iga Disease |
4.3% |
| Renal Impairment |
4.3% |
| Thrombocytopenia |
3.8% |
| Upper Gastrointestinal Haemorrhage |
3.8% |
| International Normalised Ratio Increased |
3.4% |
| Respiratory Arrest |
3.4% |
| Diarrhoea |
3.0% |
| Malaise |
3.0% |
| Pain |
3.0% |
| Renal Failure |
3.0% |
| Skin Exfoliation |
3.0% |
| Swelling Face |
3.0% |
| Wheezing |
3.0% |
|
| Secondary |
| Product Used For Unknown Indication |
23.0% |
| Rheumatoid Arthritis |
12.2% |
| Pain |
10.1% |
| Drug Use For Unknown Indication |
8.1% |
| Osteoarthritis |
7.4% |
| Osteoporosis |
6.7% |
| Myalgia |
6.6% |
| Hypermobility Syndrome |
6.3% |
| Drug Abuse |
3.8% |
| Hypertension |
3.7% |
| Headache |
2.9% |
| Back Pain |
1.6% |
| Bone Disorder |
1.3% |
| Respiratory Disorder |
1.3% |
| Arthralgia |
1.1% |
| Psoriatic Arthropathy |
1.0% |
| Type 2 Diabetes Mellitus |
0.8% |
| Hiv Infection |
0.8% |
| Atrial Fibrillation |
0.7% |
| Spinal Osteoarthritis |
0.7% |
|
| Suicidal Ideation |
16.8% |
| Renal Failure Acute |
13.3% |
| Vomiting |
11.3% |
| Suicide Attempt |
5.7% |
| Toxicity To Various Agents |
5.2% |
| Rectal Haemorrhage |
4.6% |
| Renal Failure |
4.6% |
| Toxic Epidermal Necrolysis |
4.4% |
| Completed Suicide |
3.9% |
| Tubulointerstitial Nephritis |
3.5% |
| Galactorrhoea |
3.3% |
| Renal Tubular Necrosis |
3.1% |
| Weight Decreased |
3.1% |
| Rhabdomyolysis |
2.8% |
| Tachycardia |
2.6% |
| Urticaria |
2.6% |
| International Normalised Ratio Increased |
2.4% |
| Myocardial Infarction |
2.4% |
| Stevens-johnson Syndrome |
2.4% |
| Cytolytic Hepatitis |
2.2% |
|
| Concomitant |
| Rheumatoid Arthritis |
21.6% |
| Product Used For Unknown Indication |
20.3% |
| Drug Use For Unknown Indication |
18.8% |
| Pain |
8.3% |
| Hypertension |
5.7% |
| Prophylaxis |
3.3% |
| Depression |
2.7% |
| Psoriatic Arthropathy |
2.1% |
| Arthritis |
2.0% |
| Ankylosing Spondylitis |
1.8% |
| Osteoporosis |
1.8% |
| Arthralgia |
1.8% |
| Non-small Cell Lung Cancer |
1.6% |
| Diabetes Mellitus |
1.4% |
| Back Pain |
1.3% |
| Hiv Infection |
1.3% |
| Anxiety |
1.2% |
| Blood Cholesterol Increased |
1.2% |
| Asthma |
1.1% |
| Gastrooesophageal Reflux Disease |
1.0% |
|
| Vomiting |
13.1% |
| Weight Decreased |
7.9% |
| Pain |
7.1% |
| Urinary Tract Infection |
6.1% |
| Weight Increased |
6.0% |
| Myocardial Infarction |
5.5% |
| Pneumonia |
5.4% |
| Pain In Extremity |
4.9% |
| Rheumatoid Arthritis |
4.7% |
| Nausea |
4.4% |
| Death |
4.1% |
| Drug Ineffective |
4.1% |
| Pyrexia |
4.0% |
| Pulmonary Embolism |
3.3% |
| Sepsis |
3.3% |
| Vision Blurred |
3.3% |
| Somnolence |
3.3% |
| Urticaria |
3.3% |
| Thrombocytopenia |
3.1% |
| Rash |
3.0% |
|
| Interacting |
| Hypertension |
19.1% |
| Pain |
12.8% |
| Type 2 Diabetes Mellitus |
8.5% |
| Product Used For Unknown Indication |
6.7% |
| Coronary Artery Disease |
5.7% |
| Drug Use For Unknown Indication |
5.3% |
| Dyslipidaemia |
5.0% |
| Hyperlipidaemia |
4.6% |
| Bronchial Carcinoma |
4.3% |
| Deep Vein Thrombosis |
4.3% |
| Cerebral Infarction |
3.5% |
| Glaucoma |
2.5% |
| Ischaemic Heart Disease Prophylaxis |
2.5% |
| Lung Infection |
2.5% |
| Cancer Pain |
2.1% |
| Cardiac Failure |
2.1% |
| Juvenile Arthritis |
2.1% |
| Nephrogenic Anaemia |
2.1% |
| Osteoarthritis |
2.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.1% |
|
| Renal Failure Acute |
20.0% |
| Drug Interaction |
13.3% |
| Somnolence |
11.1% |
| Renal Failure |
6.7% |
| Skin Exfoliation |
6.7% |
| Urinary Retention |
6.7% |
| Haemorrhage |
4.4% |
| Liver Function Test Abnormal |
4.4% |
| Blood Glucose Increased |
2.2% |
| Dizziness |
2.2% |
| Gastrointestinal Haemorrhage |
2.2% |
| Hypovolaemia |
2.2% |
| Metabolic Acidosis |
2.2% |
| Multiple Drug Overdose Intentional |
2.2% |
| Obstructive Airways Disorder |
2.2% |
| Off Label Use |
2.2% |
| Pancytopenia |
2.2% |
| Propofol Infusion Syndrome |
2.2% |
| Skin Plaque |
2.2% |
| Spinal Haematoma |
2.2% |
|
